Skip to main content
Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.955
-0.105 (-9.88%)
At close: Apr 28, 2026, 4:00 PM EDT
0.940
-0.016 (-1.62%)
Pre-market: Apr 29, 2026, 6:07 AM EDT

SNTI Revenue

In the year 2025, Senti Biosciences Holdings had annual revenue of $22.00K. Senti Biosciences Holdings had revenue of $22.00K in the quarter ending December 31, 2025.

Revenue (ttm)
$22.00K
Revenue Growth
n/a
P/S Ratio
1,352.38
Revenue / Employee
$647
Employees
34
Market Cap
29.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202522.00K--
Dec 31, 2024---
Dec 31, 20232.56M-1.73M-40.25%
Dec 31, 20224.29M1.53M55.23%
Dec 31, 20212.76M2.20M387.81%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Celularity 40.58M
Palatin Technologies 8.96M
Evaxion 7.53M
CervoMed 4.01M
Pluri 1.34M
IGC Pharma 1.11M
Outlook Therapeutics 205.70K
Revenue Rankings

SNTI News

More News